Long noncoding RNA TARID directs demethylation and activation of the tumor suppressor TCF21 via GADD45A

Khelifa Arab, Yoon Jung Park, Anders M. Lindroth, Andrea Schäfer, Christopher Oakes, Dieter Weichenhan, Annekatrin Lukanova, Eva Lundin, Angela Risch, Michael Meister, Hendrik Dienemann, Gerhard Dyckhoff, Christel Herold-Mende, Ingrid Grummt, Christof Niehrs, Christoph Plass

Research output: Contribution to journalArticlepeer-review

237 Scopus citations


DNA methylation is a dynamic and reversible process that governs gene expression during development and disease. Several examples of active DNA demethylation have been documented, involving genome-wide and gene-specific DNA demethylation. How demethylating enzymes are targeted to specific genomic loci remains largely unknown. We show that an antisense lncRNA, termed TARID (for TCF21 antisense RNA inducing demethylation), activates TCF21 expression by inducing promoter demethylation. TARID interacts with both the TCF21 promoter and GADD45A (growth arrest and DNA-damage-inducible, alpha), a regulator of DNA demethylation. GADD45A in turn recruits thymine-DNA glycosylase for base excision repair-mediated demethylation involving oxidation of 5-methylcytosine to 5-hydroxymethylcytosine in the TCF21 promoter by ten-eleven translocation methylcytosine dioxygenase proteins. The results reveal a function of lncRNAs, serving as a genomic address label for GADD45A-mediated demethylation of specific target genes.

Original languageEnglish
Pages (from-to)604-614
Number of pages11
JournalMolecular Cell
Issue number4
StatePublished - 21 Aug 2014

Bibliographical note

Funding Information:
We thank Oliver Mücke and Jana Petersen for technical assistance. This work was supported by funding from the Helmholtz Foundation, the German Consortium for Cancer Research, and the National Institutes of Health, DE13123 to C.P. and by an ERC senior investigator grant N°249826-“DNAdemethylase” to C.N. I.G.’s work has been supported by the DFG (GR475/22-1, SFB1036), the excellence cluster CellNetworks, and the ERC (N°232645). Melanoma cell line C8161 and pEF-FH-TET1 were kindly provided by Dr. Mary Hendrix (Children’s Hospital of Chicago Research Center) and Dr. Anjana Rao (La Jolla Institute for Allergy and Immunology), respectively.


Dive into the research topics of 'Long noncoding RNA TARID directs demethylation and activation of the tumor suppressor TCF21 via GADD45A'. Together they form a unique fingerprint.

Cite this